Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Volumn 27, Issue 5, 2012, Pages 1746-1755

  Zhang, Bin ^a   Xie, Shaoting ^b   Shi, Wei ^b   Yang, Yun ^b  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; BETA3 INTEGRIN; EPITHELIAL SODIUM CHANNEL; LIPOPOLYSACCHARIDE; SODIUM CHANNEL BLOCKING AGENT; TRIAMTERENE; UROKINASE RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL MOTION; DISEASE MODEL; DRUG EFFECT; FOCAL GLOMERULOSCLEROSIS; IN VITRO STUDY; MALE; METABOLISM; MOUSE; NEPHRECTOMY; PATHOLOGY; PODOCYTE; PROTEINURIA; RAT;

AMILORIDE; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL SODIUM CHANNELS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; INTEGRIN BETA3; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NEPHRECTOMY; PODOCYTES; PROTEINURIA; RATS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SODIUM CHANNEL BLOCKERS; TRIAMTERENE;

EID: 84862119511     PISSN: None     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr612     Document Type: Article

References (0)